These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1954544)

  • 21. [Syndrome of chronic intravascular coagulation in the course of chronic myeloid leukemia].
    Rusinowska Z; Stella-Hołowiecka B
    Wiad Lek; 1994 Jul; 47(13-14):544-6. PubMed ID: 7716945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden apparent worsening of diabetic retinopathy leading to a diagnosis of chronic myeloid leukaemia.
    Shahid SM; Waqar S; Ling R
    Br J Hosp Med (Lond); 2013 Sep; 74(9):533. PubMed ID: 24022560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular remission of chronic myeloid leukaemia in a patient with hepatitis and a second kidney transplant].
    Castillo-Rama M; Grande C; Martínez-Sanchez P; Olavarria E; Marín D; Paz-Artal E; Andrés A; Morales JM
    Nefrologia; 2009; 29(6):604-7. PubMed ID: 19936007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Chronic myeloid leukaemia presenting as priapism in children: need for multidisciplinary approach.
    Nabi G; Dogra PN
    East Afr Med J; 2000 Oct; 77(10):576. PubMed ID: 12862132
    [No Abstract]   [Full Text] [Related]  

  • 25. Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis.
    Jallades L; Hayette S; Tigaud I; Johnston A; Coiffier B; Magaud JP; Ffrench M
    Leuk Res; 2008 Oct; 32(10):1608-10. PubMed ID: 18448166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial calcification and left ventricular aneurysm in chronic myeloid leukaemia.
    Madhu SV; Tewari A; Agarwal SK; Makkar BM
    J Assoc Physicians India; 1993 May; 41(5):308-9. PubMed ID: 8300468
    [No Abstract]   [Full Text] [Related]  

  • 27. Spontaneous splenic rupture in atypical (Philadelphia chromosome negative) chronic myeloid leukaemia following blastic crisis.
    Sachithanandan A; Gleadhill I; Alexander HD; Morris TC
    Ir Med J; 2003 Jun; 96(6):181-2. PubMed ID: 12926761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiotherapy in advanced osseous destruction in chronic myeloid leukemia. A case report].
    Sadick M; Maurer U
    Strahlenther Onkol; 1996 Jun; 172(6):330-1. PubMed ID: 8677506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nephrotic syndrome in a patient with chronic myeloid leukemia].
    Majdan M; Chibowski D; Siezieniewska Z; Berger B; Ksiazek A
    Pol Tyg Lek; 1988 Dec; 43(50):1635-6. PubMed ID: 3256807
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells.
    Withey JM; Marley SB; Kaeda J; Harvey AJ; Crompton MR; Gordon MY
    Br J Haematol; 2005 May; 129(3):377-80. PubMed ID: 15842662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poland's syndrome associated with chronic granulocytic leukemia.
    Costa R; Afonso E; Benedito M; Maricato L
    Sangre (Barc); 1991 Oct; 36(5):417-8. PubMed ID: 1816637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic myeloid leukemia and carcinoma of the prostate].
    Papineschi F; Bonini R; Pistolisi D; Spremolla G
    Sangre (Barc); 1989 Oct; 34(5):383. PubMed ID: 2533407
    [No Abstract]   [Full Text] [Related]  

  • 33. Algorithm for initial management of priapism in chronic myeloid leukaemia.
    Chisick L; Seftel M; Kumar R
    Br J Haematol; 2012 Oct; 159(2):250-1. PubMed ID: 22924590
    [No Abstract]   [Full Text] [Related]  

  • 34. Diffuse depigmentation in a patient with chronic myeloid leukemia.
    Chan CC; Yao M; Tsai TF
    J Am Acad Dermatol; 2006 Apr; 54(4):738-40. PubMed ID: 16546610
    [No Abstract]   [Full Text] [Related]  

  • 35. Spurious anoxaemia in a patient with chronic myeloid leukaemia.
    Wong KF; Leung VK; Ma SK; Ma YH
    Clin Lab Haematol; 1992; 14(3):263-4. PubMed ID: 1451407
    [No Abstract]   [Full Text] [Related]  

  • 36. Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia.
    Milojkovic D; Short K; Salisbury JR; Creamer D; du Vivier AW; Mufti GJ
    Leukemia; 2003 Jul; 17(7):1414-6. PubMed ID: 12835733
    [No Abstract]   [Full Text] [Related]  

  • 37. Significance of haemoglobin-S in the pathogenesis of hyperleucocytic syndromes in Nigerian patients with chronic myeloid leukaemia.
    Ahmed SG; Ibrahim UA
    Eur J Haematol; 2007 Aug; 79(2):174-6. PubMed ID: 17573919
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Priapism, complicating chronic myeloid leukemia--a case report.
    Agrawal DK; Jha S; Verma A; Tripathi AK; Singh BN
    Indian J Cancer; 1991 Mar; 28(1):51-2. PubMed ID: 1769683
    [No Abstract]   [Full Text] [Related]  

  • 40. Paraneoplastic cutaneous leucocytoclastic vasculitis in chronic myeloid leukemia: case report and review of the literature.
    Krishnan K; Silveira S
    Eur J Haematol; 1994 Mar; 52(3):187-8. PubMed ID: 8168601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.